WIPO WIPO 2007

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark was filed as Figurative mark on 11/01/2007 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Circles #Lines, bands #Circles containing other figurative elements #Circles with dark surfaces or parts of surfaces #Curved lines or bands (except A 26.11.13)

Trademark Details Last update: March 20, 2018

Trademark form Figurative mark
File reference 972485
Countries em
Base trademark US No. , July 3, 2024
Application date November 1, 2007
Expiration date November 1, 2027

Trademark owner

2525 Dupont Drive
Irvine, CA 92612
US

goods and services

05 Pharmaceutical products for use in the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; pre-filled drug cartridges, sold with inhalers, which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; pre-filled drug cartridges, sold with inhalers, which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the delivery of cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations.
42 Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices, both with and without pre-filled drug cartridges, for delivery of medication via the pulmonary route; medical and scientific research, namely conducting clinical trials.

Trademark history

Date Document number Area Entry
November 1, 2017 2017/45 Gaz Extension
April 6, 2012 2013/7 Gaz US RAW: Partial Ceasing Effect
July 20, 2009 2009/30 Gaz EM RAW: Protection Granted
November 19, 2008 2008/48 Gaz US RAW: Division or Merger of Basic Registration
November 1, 2007 2008/34 Gaz US Registration

ID: 14972485